High-Throughput Quantitative Analysis of Hepatitis B Virus DNA in Serum Using the TaqMan Fluorogenic Detection System
- 1 September 2000
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 32 (3), 626-629
- https://doi.org/10.1053/jhep.2000.9878
Abstract
Reproducible quantitative assays to detect viral nucleic acids have proven useful in defining disease progression and following response to therapy in a wide variety of viral infections. We describe the development of a quantitative assay to detect hepatitis B virus (HBV) DNA using real-time fluorescent-probe polymerase chain reaction (PCR) (TaqMan). The assay is highly reproducible, highly automated, and much more sensitive than the currently used branched-chain DNA (bDNA) assay for HBV. The quantitative PCR assay accurately detected samples ranging from 10 to 10(9) copies of HBV DNA per milliliter. Of 157 serum samples submitted for HBV quantitation, 119 were positive by TaqMan PCR versus only 55 by bDNA (P <.001). All 55 bDNA-positives were positive by TaqMan. Of the 77 samples with detectable HBV-DNA titers below 3.75 x 10(5) copies by TaqMan, only 13 were detected by bDNA. We tested 119 patients negative for all HBV serologic markers, and all tested negative in the TaqMan assay. HBV DNA was detected by TaqMan in 164 of 195 (84%) of hepatitis B surface antigen (HBsAg)-positive samples. Among hepatitis B e antigen (HBeAg)-positive samples, median titers were 4. 3 x 10(6) copies/mL versus 322 copies/mL in HBeAg-negative samples (P =.012). The TaqMan assay for HBV DNA is highly sensitive and reproducible and thus appears useful in accurately defining levels of viral replication among persons with HBV infection.Keywords
This publication has 17 references indexed in Scilit:
- Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis BJournal of Medical Virology, 1999
- Update on Diagnosis, Management, and Prevention of Hepatitis B Virus InfectionClinical Microbiology Reviews, 1999
- Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Real time quantitative PCR.Genome Research, 1996
- Quantitation of HBV DNA in Human Serum Using a Branched DNA (bDNA) Signal Amplification AssayAmerican Journal of Clinical Pathology, 1995
- Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virusJournal of Hepatology, 1995
- Serum Hepatitis B Virus DNA in Hepatitis B Virus Seropositive and Seronegative Patients with Normal Liver FunctionAmerican Journal of Clinical Pathology, 1991
- A precore‐defective mutant of hepatitis B virus associated with e antigen‐negative chronic liver diseaseJournal of Medical Virology, 1990
- Detection of hepatitis B virus DNA in serum by polymerase chain reactionGastroenterology, 1990